FDA inspection
Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer, Inc.: FDA inspection ending Apr 20, 2000
FDA inspection 20764 · Voluntary Action Indicated (VAI) · Rouses Point, NY
Key facts
| Inspection ID | 20764 |
|---|---|
| Firm | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer, Inc. |
| FEI number | 1310337 |
| Address | 64 Maple St |
| City | Rouses Point |
| State | NY |
| ZIP | 12979-1424 |
| Fiscal year | 2000 |
| Inspection end date | Apr 20, 2000 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data